Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Pain, Postoperative 1Pain 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × Narcotics × Clear all
NCT03393117 2020-07-22

Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction

Case Comprehensive Cancer Center

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT02044302 2017-04-10

A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction

Yale University

Phase 2 Terminated
2 enrolled 3 charts
Breast

Breast Neoplasms, Pain, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡